---
title: "Stem Cell Therapy for Peripheral Neuropathy: What the Research Shows and Who May Be a Candidate"
description: "An honest guide to mesenchymal stem cell (MSC) therapy for peripheral and diabetic neuropathy: what the limited research shows, our two protocols and prices, risks, and who may be a candidate."
canonical: "https://dreambody.clinic/stem-cell-therapy-peripheral-neuropathy/"
---

# Stem Cell Therapy for Peripheral Neuropathy: What the Research Shows and Who May Be a Candidate

If you have peripheral neuropathy, you probably know the feeling well: burning or pins and needles in your feet, numbness that makes you unsure of your footing, pain that’s worst when you’re trying to sleep. Maybe you’ve been on gabapentin, pregabalin or duloxetine for a while. They take the edge off for some people, and leave others groggy and still sore.

Mesenchymal stem cell (MSC) therapy comes up a lot when people start looking past pain pills. This guide explains what peripheral neuropathy is, what the published research on stem cells actually shows, exactly what our two neuropathy protocols involve and cost, and who may be a reasonable candidate. MSC therapy for neuropathy is investigational. The human evidence is early and mixed, nobody can promise you a result, and it doesn’t replace the care you already have.

## What Peripheral Neuropathy Is

Peripheral neuropathy means damage to the nerves outside the brain and spinal cord. It usually starts in the feet and can move up the legs and into the hands. Depending on which nerve fibers are affected, you may notice:

- Burning, tingling, electric or stabbing pain
- Numbness or reduced feeling, especially in the feet
- Poor balance or a sense of walking on cotton
- Weakness or cramping
- Sometimes changes in sweating, blood pressure or digestion when the automatic (autonomic) nerves are involved

**The cause matters more than the label.** Diabetes is the most common cause in the United States. Others include chemotherapy, heavy alcohol use, low vitamin B12, thyroid disease, kidney disease, some autoimmune and inherited conditions, infections, nerve compression and injury. A significant share of cases have no cause found after testing. That’s why a proper workup comes before any talk of treatment. Some causes, like a B12 deficiency, have a much more direct fix than a cell procedure.

## What Standard Care Can and Can't Do

For most types of neuropathy, standard care has two goals: deal with the cause and manage symptoms. In diabetic neuropathy, steady blood sugar control can slow progression. Daily foot checks, good footwear and regular visits with a podiatrist help prevent ulcers and infections, which are the most serious complications.

For pain, medicines such as pregabalin, gabapentin, duloxetine and some older antidepressants are commonly used, and in the U.S. the FDA has approved pregabalin, duloxetine and tapentadol ER specifically for painful diabetic neuropathy. Topical treatments, physical therapy and balance training help some people too.

The honest gap is this: these treatments manage pain and protect the feet, but none has been shown to restore nerve fibers that are already lost. That gap is real, and it’s why people look at regenerative options. It isn’t, by itself, evidence that stem cells close it.

## How MSCs Are Thought to Work

MSCs are best understood as signaling cells. Most of what they appear to do happens through paracrine signaling: they release proteins and tiny packets of molecules that influence nearby immune cells, blood vessels and supporting nerve cells (Schwann cells). In lab and animal work, those signals include nerve growth factors such as NGF, BDNF and GDNF, plus factors that encourage blood vessel growth.

They don’t turn into new nerve cells in your body. The idea is that their signals might calm inflammation, support blood supply to the nerves and help your own repair processes. That’s a reasonable biological rationale. It isn’t proof that an injection will reduce your pain or bring back feeling.

## What Does the Research Show?

Here’s a plain summary of the strongest evidence we’re aware of, mostly in diabetic peripheral neuropathy, which has been studied the most.

- **Animal studies are consistently encouraging.** A 2024 review in *Frontiers in Bioengineering and Biotechnology* pooled 23 animal studies and found that MSCs improved nerve conduction, small nerve fiber counts and nerve blood flow in diabetic rodents. Animal results often don’t carry over to people, so this tells us the idea is worth testing, not that it works in humans.
- **Human trials are few and small.** A 2024 systematic review in *Stem Cell Research & Therapy* screened more than 5,000 records and found only seven controlled human trials. Combined, they showed modest improvements in nerve conduction speed (about 2 meters per second), vibration sense and a neuropathy symptom score. Injection-site pain and swelling that cleared within days were the main side effects. But only one of the seven trials was properly randomized, most used bone marrow cells or umbilical cord MSCs injected into leg muscles, and the studies were small.
- **The best-controlled trial was negative on its main goal.** In a phase 2 randomized, placebo-controlled trial (published in the *Journal of the Peripheral Nervous System* in 2021), 26 people with diabetic neuropathy received three rounds of placenta-derived cell injections into one leg, or placebo. The cells were well tolerated, but there was no significant change in small nerve fiber density or symptom scores compared with placebo.

So the picture is early and mixed: some measurable changes in nerve function in small, mostly unblinded studies, and no change in the one well-designed placebo trial. For chemotherapy-induced, autoimmune or idiopathic neuropathy, human MSC data are thinner still.

We’re also not aware of a published trial that used our exact approach: donor MSCs from Wharton’s jelly and placenta injected at the top of the foot, or a 200 million-cell IV combined with an intrathecal (spinal fluid) injection. Our protocols are based on our physicians’ experience and the broader science of MSC signaling, not on a neuropathy trial of the same product, dose and route.

## What Stem Cell Therapy Can and Can't Do

- It is **not** a cure for neuropathy, and it isn’t shown to regrow lost nerve fibers in people.
- It does **not** treat the underlying cause. If diabetes, B12 deficiency or chemotherapy caused the damage, managing that still matters most.
- It is **not** a replacement for blood sugar control, foot care or medicines your own doctor prescribes.
- It **may** reduce burning, tingling or pain for some people over the following months. Some people notice little or no change.

## Our Two Neuropathy Protocols

We offer two published protocols. Which one fits, if either, depends on where your symptoms are and what’s causing them, and a physician makes that call after reviewing your records.

|  | **Foot neuropathy** | **Peripheral neuropathy (systemic)** |
| --- | --- | --- |
| **Who it’s for** | Symptoms mainly in the feet | More widespread symptoms |
| **Cells** | 25 million MSCs injected at the top of the foot, near where the nerves run | 200 million MSCs by IV, plus 50 million by intrathecal injection into the spinal fluid |
| **Also included** | Full blood panel | NAD+ and high-dose vitamin C IV drip after the stem cells, and a full blood panel |
| **Price** | $1,750 USD | $11,500 USD |
| **Minimum stay** | 4 days | 5 days |

Details are on our [foot neuropathy treatment page](https://dreambody.clinic/stem-cell-foot-neuropathy-treatment/) and our [peripheral neuropathy treatment page](https://dreambody.clinic/peripheral-neuropathy-stem-cell-treatment-to-heal-nerve-pain/).

A note on the larger protocol, because you should know it: the intrathecal step adds risk and cost, and we’re not aware of published trials showing that intrathecal MSCs help peripheral neuropathy. Ask our physician to explain why it would or wouldn’t make sense in your case.

Our cells are grown in our own lab in Bucerías, which holds three COFEPRIS licenses (Mexico’s federal health regulator) covering stem cell production, cryobank storage and regenerative medicine practice. Cells are expanded in a GMP-grade, xeno-free medium in a cleanroom, tested by COFEPRIS-authorized third-party labs for identity (flow cytometry), mycoplasma and endotoxins, and given within 24 hours of leaving culture. You can see the licenses on our [certified stem cells page](https://dreambody.clinic/certified-stem-cells/), and our article on [how our cells are made and tested](https://dreambody.clinic/science-and-quality-of-our-mesenchymal-stem-cells/) explains more.

COFEPRIS licenses our facility and lab. That isn’t the same as approving stem cell therapy for neuropathy, and these treatments are not FDA-approved in the United States.

## Risks and Side Effects

We’d rather you hear about risks from us before you book. Based on our experience with these protocols:

- **Foot injection:** soreness or tightness the night after or the next day is the most common effect. Any injection carries a small infection risk. That matters more if you have diabetes, poor circulation or reduced feeling in your feet, so watch the site closely.
- **IV infusion:** fever or headache for a few hours or the next day in about 1 in 100 patients. Clots or vein irritation are a rare risk with any IV, which is one reason we do bloodwork first.
- **Intrathecal injection:** in about 1 in 30 patients, lower back pain near the injection site for a few hours to a few days. In about 1 in 30, a migraine-like headache, sometimes with nausea, that can last a few hours to a few days.
- **No response.** Some patients notice no change.
- **Unknown long-term effects.** Long-term safety data for donor MSCs in neuropathy are limited. The U.S. FDA has warned consumers about unapproved stem cell products and reported serious harms from some of them elsewhere. That’s part of why we publish our protocols, licenses and testing, and why a physician reviews every case before booking.

**Medicines.** Some medicines, including blood thinners, anti-inflammatories and steroids, affect whether and when these procedures can be done, and the intrathecal injection can’t be done while you’re on blood thinners. Please don’t stop or change any prescribed medication, including diabetes medicines, aspirin or blood thinners, on your own. We’ll review your list during the consultation and coordinate with your own doctor.

## Who May Be a Candidate?

A physician reviews every case before you book. In general, people who may be reasonable candidates:

- Have a neuropathy diagnosis from their own doctor, ideally with a known cause and recent testing
- Have the underlying cause as well managed as possible, for example stable blood sugar in diabetes
- Have already tried recommended care and still have bothersome symptoms
- Understand the treatment is investigational, may not help, and is an addition to regular care
- Are well enough to travel

You may not be a good candidate if:

- You’ve had cancer in the past five years (we don’t treat these patients). If your neuropathy came from chemotherapy, this applies to you, so ask us early.
- You have an active infection, an open foot wound or ulcer, or bloodwork suggests a problem
- Your symptoms haven’t been worked up, or a treatable cause such as B12 deficiency, thyroid disease or nerve compression hasn’t been ruled out
- You need blood thinners you can’t safely pause (this rules out the intrathecal step)
- Sudden or rapidly worsening weakness or numbness. That needs urgent medical care at home, not a trip.

If we don’t think treatment is likely to be worthwhile for you, we’ll tell you.

## Your Trip

| Day | Foot protocol (4 days) | Systemic protocol (5 days) |
| --- | --- | --- |
| **Day 1** | Arrive and rest | Arrive and rest |
| **Day 2** | Bloodwork, then payment | Bloodwork, then payment |
| **Day 3** | Foot injection | IV infusion, NAD+ and vitamin C drip, and intrathecal injection |
| **Day 4** | Fly home | Rest |
| **Day 5** |  | Fly home |

Exact days can shift with scheduling, and you’re welcome to stay longer. If numbness affects your balance, tell us early so we can plan transport and help at the airport. Our [travel guide](https://dreambody.clinic/travel-guide-stem-cell-treatment-bucerias/) and [hotel options](https://dreambody.clinic/hotels/) can help you plan.

## After Treatment

After the foot protocol, we advise two weeks off exercise and sports, then a four-week rehab program we provide, with a light return to activity after about six weeks. Changes, if they come, tend to be gradual. Many patients tell us they notice the most difference between 3 and 6 months, but results vary and some people notice little or no change.

Before you travel, record a simple baseline with your own doctor: pain and tingling scores, sleep, balance, and any test results such as a nerve conduction study or vibration test. That way any change can be measured rather than remembered. Keep up your foot checks, blood sugar control and current treatment plan. We follow up remotely at 3, 6 and 12 months.

**Seek medical care right away** if you develop redness, warmth, swelling or drainage at an injection site, a fever that doesn’t settle, a severe headache that won’t ease, new weakness or numbness, chest pain or trouble breathing.

## Questions to Ask Any Clinic

Whether you choose us or someone else, ask:

1. What published study supports this exact cell product, dose and route for my type of neuropathy?
2. Why this route (foot, IV or spinal), and what extra risk does it add?
3. Are the cells tested before use, and by whom?
4. Who decides what happens to my diabetes medicines and blood thinners?
5. How will we measure whether anything changed?
6. What does the price include, and what happens if bloodwork shows I shouldn’t proceed?

Our guides on [how to choose a stem cell clinic](https://dreambody.clinic/how-to-choose-a-stem-cell-clinic/) and [what stem cell therapy costs in Mexico](https://dreambody.clinic/stem-cell-therapy-cost-mexico/) go deeper.

## Frequently Asked Questions

**Can stem cells cure neuropathy or regrow my nerves?** No. MSC therapy for neuropathy is investigational. Small studies show some changes in nerve function, and the best placebo-controlled trial found no significant benefit. Some people report less pain or tingling over the following months. Some notice little or no change.

**Does it work for diabetic neuropathy?** Diabetic neuropathy has the most research, and the results are early and mixed. Blood sugar control and foot care stay essential whatever you decide.

**Which protocol would I need?** It depends on where your symptoms are and what’s causing them. A physician will recommend one, or neither, after reviewing your records.

**Will I be able to stop my neuropathy medication?** Don’t stop or change any medicine without your own doctor. These protocols are offered as an addition to regular care.

**Will insurance cover it?** Insurance generally doesn’t cover stem cell therapy for neuropathy, and many U.S. insurers classify it as experimental.

## Thinking About Your Options?

If you’re wondering whether MSC therapy is a reasonable thing to explore alongside your current care, a free consultation is a good place to start. It’s a conversation, not a commitment. A physician will review your history, explain what the evidence does and doesn’t show, and tell you honestly whether either protocol makes sense for you.

**[Schedule your free consultation](https://dreambody.clinic/contact/)**, call (888) 704-3977, WhatsApp +52 322 232 1055, or email info@dreambodyclinic.net.

---

*Disclaimer: This article is for educational purposes and is not medical advice. Mesenchymal stem cell therapy for peripheral neuropathy is investigational and is not approved by the U.S. FDA. Published human evidence is limited, results vary, and some patients see little or no benefit. Treatment is provided in Mexico at a COFEPRIS-licensed facility. Do not stop or change any medication without your own doctor. Please consult your physician before making treatment decisions.*
